Jan P Kamiński1, Kenneth W Bueltmann, Marek Rudnicki. 1. Department of Surgery, University of Illinois Metropolitan Group Hospitals, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave, Chicago, IL, 60657, USA, jpkaminski@gmail.com.
Abstract
BACKGROUND AND OBJECTIVES: Robotic-assisted cholecystectomy (RAC) was introduced several years ago. With its more extensive use by surgeons, more information is needed regarding clinical and economic outcomes. METHODS: The Nationwide Inpatient Sample from the Health Cost Utilization Project was analyzed using HCUPnet, National Inpatient Sample (NIS) datasets and SAS 9.2 for the years 2010-2011. Queries were made for RAC and laparoscopic cholecystectomy (LC) procedures with a primary diagnosis of gallbladder disease. Overall charges, costs, number of chronic conditions, comorbidities, and length of stay were calculated. RESULTS: RAC was $7518, +54 % (p < 0.05), and $4044, +29 % (p < 0.05), more costly compared to LC in 2010 and 2011, respectively. Total costs for RAC decreased by 14.6 % (p = 0.27) between 2010 and 2011, even though RAC was still costlier than LC in 2011. There was no significant difference in the LOS between RAC and LC in either years. Patients undergoing RAC had an increased number of chronic conditions compared to patients undergoing LC in both 2010 and 2011. CONCLUSION: LOS of RAC is similar to LC. Cost of RAC remains higher compared to LC although there was reduction in cost of RAC in 2011 versus 2010.
BACKGROUND AND OBJECTIVES: Robotic-assisted cholecystectomy (RAC) was introduced several years ago. With its more extensive use by surgeons, more information is needed regarding clinical and economic outcomes. METHODS: The Nationwide Inpatient Sample from the Health Cost Utilization Project was analyzed using HCUPnet, National Inpatient Sample (NIS) datasets and SAS 9.2 for the years 2010-2011. Queries were made for RAC and laparoscopic cholecystectomy (LC) procedures with a primary diagnosis of gallbladder disease. Overall charges, costs, number of chronic conditions, comorbidities, and length of stay were calculated. RESULTS: RAC was $7518, +54 % (p < 0.05), and $4044, +29 % (p < 0.05), more costly compared to LC in 2010 and 2011, respectively. Total costs for RAC decreased by 14.6 % (p = 0.27) between 2010 and 2011, even though RAC was still costlier than LC in 2011. There was no significant difference in the LOS between RAC and LC in either years. Patients undergoing RAC had an increased number of chronic conditions compared to patients undergoing LC in both 2010 and 2011. CONCLUSION: LOS of RAC is similar to LC. Cost of RAC remains higher compared to LC although there was reduction in cost of RAC in 2011 versus 2010.
Authors: Carsten N Gutt; Jens Encke; Jörg Köninger; Julian-Camill Harnoss; Kilian Weigand; Karl Kipfmüller; Oliver Schunter; Thorsten Götze; Markus T Golling; Markus Menges; Ernst Klar; Katharina Feilhauer; Wolfram G Zoller; Karsten Ridwelski; Sven Ackmann; Alexandra Baron; Michael R Schön; Helmut K Seitz; Dietmar Daniel; Wolfgang Stremmel; Markus W Büchler Journal: Ann Surg Date: 2013-09 Impact factor: 12.969
Authors: Ajit Rao; Antonio Polanco; Sujing Qiu; Joseph Kim; Edward H Chin; Celia M Divino; Scott Q Nguyen Journal: J Am Coll Surg Date: 2013-09-14 Impact factor: 6.113
Authors: Marya D Zilberberg; Andrew F Shorr; Huan Huang; Paresh Chaudhari; Victoria Federico Paly; Joseph Menzin Journal: BMC Infect Dis Date: 2014-06-05 Impact factor: 3.090
Authors: James C Patti; Ana Sofia Ore; Courtney Barrows; Vic Velanovich; A James Moser Journal: Hepatobiliary Surg Nutr Date: 2017-08 Impact factor: 7.293
Authors: Shahida Bibi; Amir A Rahnemai-Azar; Jasna Coralic; Mohamed Bayoumi; Joubin Khorsand; Daniel T Farkas; Leela M Prasad Journal: World J Surg Date: 2015-10 Impact factor: 3.352